The government of Austria has introduced a national lottery to encourage people to get vaccinated against COVID-19, Reuters news agency reported on Thursday.
Around 72% of Austria's population is fully vaccinated against COVID-19, one of the lowest rates in western Europe.
Chancellor Karl Nehammer said he wanted there to be a financial reward for those who get vaccinated, adding: "We have learned from the past and we have seen that a vaccination lottery is the best possible way to set up such a system."
Members of the public, whether already vaccinated or not, would get a ticket for each shot they have -- three tickets in total for those who have had their booster shot.
Every tenth ticket would win a EUR500 gift voucher, Nehammer said, without specifying what the vouchers were for.
This comes as Austria's lower house of parliament is due to pass a bill making vaccines compulsory for all adults in Austria from 1 February 2022, with initial fines of EUR600 rising to up to EUR3,600 if the fine is challenged unsuccessfully.
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine
TransCode acquires Polynoma and secures USD25m investment from CK Life Sciences
Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio